Review
Copyright ©The Author(s) 2021.
World J Gastroenterol. Dec 21, 2021; 27(47): 8081-8102
Published online Dec 21, 2021. doi: 10.3748/wjg.v27.i47.8081
Figure 1
Figure 1 The main therapeutic targets and the drugs under development for hepatitis B. HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; cccDNA: Covalently closed circular DNA.
Figure 2
Figure 2 Shows the timeline of antiviral treatment for hepatitis C virus. HCV: Hepatitis C virus; IFN: Interferon; RBV: Ribavirin; Peg: Pegylated; DAA: Direct-acting antiviral; WHO: World Health Organization.
Figure 3
Figure 3 Proposals for the management of hepatitis C. MSM: Men who have sex with men; SMD: Severe mental disorder; Ag: Antigen; HCV: Hepatitis C virus; NGO: Non-governmental organization.